Skip to content
AlternativeMed
Wild yam (Dioscorea villosa) vine
Wild yam (Dioscorea villosa). The root is the part used.

Herbs & Botanicals · Herbs · Root used for menopause symptoms, with low-certainty evidence and a popular myth about progesterone

Wild yam

Dioscorea villosa L. · also called Wild yam (not the same as food yams or other Dioscorea species)

Wild yam is a North American vine in the yam family. Its root (rhizome) is used in creams and supplements, mostly for menopause symptoms. It contains diosgenin, which drug makers use in the lab to make steroid hormones. The human body does not do this, and there is no evidence that it does.

General information, not medical advice. Last substantive update · Not medically reviewed. A named clinician has not signed off on this page. How this page is made

Get your Wild yam today. Order now from Amazon and have it delivered to your door.Shop Wild yam on AmazonSupport our free guides: as an Amazon Associate we earn from qualifying purchases.

About Wild yam

Wild yam (Dioscorea villosa) is a North American vine whose root is used for menopause symptoms. The research is one small null trial of a cream, trials of other yam species, and lab and animal work. Nothing is rated moderate or high. The popular claim that the body turns it into progesterone is not supported.

What it is

Wild yam (Dioscorea villosa L.) is a vine in the yam family (Dioscoreaceae). Its accepted name was checked in GBIF and NCBI Taxonomy. The root (rhizome) is the part used.

It is not the same as the food yams eaten in many countries, such as Dioscorea alata, and it is not the same as steroid drugs made in factories from diosgenin. This page keeps these separate.

8 17 4

Traditional and current uses

Reviews describe wild yam being used for menopause symptoms, stomach and gut problems, muscle spasm, asthma, joint pain and rheumatoid arthritis. Today it is sold as creams, capsules and liquid extracts. Traditional use is not proof of benefit.

16 12 26

The progesterone myth

Wild yam products are often sold as 'natural progesterone'. The truth is smaller. Drug makers do use diosgenin from yams as a raw material, but they change it in a laboratory. Memorial Sloan Kettering states there is no evidence the human body can convert diosgenin into progesterone.

In the cream trial, blood and saliva progesterone did not change after 3 months. Lab studies show only weak estrogen-like effects in cells. A wild yam cream should not be used in place of prescribed progesterone.

16 11 19 13

What is in it and how it works

The root contains diosgenin and its sugar-bound form dioscin, plus other steroid-like saponins. In test tubes dioscin partly turns into diosgenin in gut fluid, and both slow a liver enzyme (CYP3A4). Saponins also act like detergents on cell membranes.

Purified diosgenin did not stimulate the rat uterus, while the whole extract acted as a weak phytoestrogen in breast cancer cells. These are lab and animal results and do not show what happens in people.

13 15 19 14 20

What the research shows

Nothing about wild yam is rated above low. A wild yam cream did no better than placebo for menopause symptoms in one small trial. A different species, Dioscorea alata, beat placebo in a 12-month trial, and a diosgenin-rich yam extract improved a thinking test in healthy adults. Period pain, cholesterol, blood sugar, joints, bone and cancer cells are very low, mixed or lab and animal only.

Species and product matter: results for other yams and for isolated diosgenin should not be treated as results for wild yam root. For amounts, ask a doctor or pharmacist.

11 9 25 10 1

At a glance

Traditional uses history, not proof

  • Herbal medicine: menopause symptoms, stomach and gut problems, muscle spasm, asthma, joint pain and rheumatoid arthritis (as described by a clinical summary and a Brazilian study).
  • The wider Dioscorea genus is used in Asia for breathing illness, rheumatism, diabetes and diarrhea, and in Africa for other conditions; North American traditional use is rarely recorded.

Studied for research

  • Menopause symptoms, wild yam cream on the skin, low (one small trial, no better than placebo)
  • Menopause symptoms, oral products of another yam species (Dioscorea alata), low
  • Thinking skills, a diosgenin-rich yam extract (species not stated), low
  • Cholesterol, mixed
  • Period pain and PMS (another yam species), very low
  • Blood sugar, joint pain, bone health and cancer cells, animal or lab work only, insufficient
  • The claim that the body turns wild yam into progesterone, evidence is against it

Main compounds

  • Diosgenin, a steroid-like plant compound
  • Dioscin, a sugar-bound form that partly turns into diosgenin in the gut (lab test)
  • Other steroidal saponins, some specific to D. villosa
  • Saponins act like detergents on cell membranes (lab)

Common forms

  • Creams and lotions with wild yam root extract
  • Capsules and liquid extracts of the root
  • Root powder and tea (traditional)
  • Not the same: food yams, other Dioscorea species, or steroid drugs made from diosgenin

Research links: Memorial Sloan Kettering: Wild yam root · Wild yam cream for menopause symptoms, randomized trial (PubMed) · Kidney injury signals in rats fed Dioscorea villosa (PubMed) · Diosgenin and dioscin in the lab: gut stability and CYP3A4 (PubMed) · GBIF: Dioscorea villosa · Research Library · Genes & Biomarkers Library

The plant and its history

Accepted scientific name
Dioscorea villosa
Naming authority
L.
Common names
Wild yam (English)
Botanical family
Dioscoreaceae (yam family)
Classification
Plantae > Tracheophyta > Liliopsida > Dioscoreales > Dioscoreaceae > Dioscorea > Dioscorea villosa
Native range
North America (per the lab paper by Manda 2013 and MSK); finer range not verified.
Habitat
Not verified.
What the plant looks like
Roots: The rhizome (underground stem) is the medicinal part (cosmetic assessment, other papers). Detail not verified.; Stems: Described as a twining vine by MSK; detail not verified.; Leaves: Not verified.; Flowers: Not verified.; Fruit: Not verified.
Cultivation
Not verified.
Harvest and processing
For the cosmetic extract, ground rhizomes are extracted with a solvent and purified (CIR 2004). Other processing not verified.
Look-alikes and adulterants
Name: Dioscorea cayenensis (a yam also sold as 'wild' or 'Mexican' yam); Note: Can be told apart from D. villosa by its saponins: asperin and gracillin only in D. cayenensis; dioscoreavilloside A and B and parvifloside only in D. villosa (Avula 2014).; Name: Dioscorea alata (greater yam or water yam, a food yam); Note: Used in the Taiwan menopause trials. A different species; its results are not wild yam results.; Name: Dioscorea esculenta (lesser yam); Note: Used in the menstrual-pain trial. A different species.; Name: Steroid drugs made from diosgenin; Note: Made in factories from diosgenin. They are drugs, not the herb, and their safety and effects do not apply to wild yam.
Sustainability and conservation
Not assessed.

Traditional use and history history, not clinical proof

Tradition or eraDocumented useSource
Herbal medicine (North America and elsewhere)Menopausal symptoms, stomach and gut problems, muscle spasm, asthma, joint pain and rheumatoid arthritisMSK clinical summary; Lima 2013 (use in Brazil)
Genus Dioscorea in Asia and AfricaRespiratory illness, rheumatism, diabetes, diarrhea, dysentery (Asia); HIV and ringworm (Africa). North American traditional use of the genus is rarely recorded.Wang 2024 review (PMID 38552992)
Pharmaceutical industryDiosgenin from yam roots used as a raw material for making steroid hormones in the laboratoryMSK summary; CIR 2004 (PMID 15513824)
Detailed history of when and where this started (for example 1940s Mexico)Appears on reference sites but was not verified from a primary source hereNOT verified

Traditional use shows how a plant was used. It does not show that a supplement works or is safe today.

What is inside, and how it may work

What the plant contains and how those compounds act in cells and animals. Laboratory and animal mechanisms are not proven effects in people.

Main compounds

CompoundFamilyWhere it is concentratedActivity studiedLevel of evidence
Diosgenin
PubChem 99474
Steroidal sapogenin (spirostanol)Rhizome
Up to 3.5% in the specified cosmetic extract
Raw material for steroid drugs. Binds the estrogen receptor in a binding assay; no estrogen-like effect in a rat uterus test. 6 29 15 20In vitro; animal
Dioscin
PubChem 119245
Steroidal saponin (glycoside of diosgenin)RhizomePartly converts to diosgenin in simulated stomach and gut fluid; inhibits CYP3A4 in test tubes. 13 21Laboratory research
Dioscoreavilloside A and B, parviflosideSteroidal saponinsRhizomeFound only in D. villosa among the two species tested; useful as identity markers. 4Lab analysis
Total steroidal saponins and diosgenin in productsMixedRhizome
0.01 to 14.5% in dry plant material; 0.9 to 28.6 mg per daily intake in solid commercial products
Content differs widely between products. 3Lab analysis

Mechanisms, receptors and pathways

Target or pathwayGene or receptorWhat was foundLevel
Estrogen receptorsEstrogen receptorDiosgenin displaced estradiol from the receptor in a binding assay (IC50 10 nM) and acted through estrogen-receptor-related signals in mouse bone cells. The extract acted as a weak phytoestrogen in MCF-7 cells, switching on progesterone receptor and pS2 genes and lowering estrogen receptor alpha protein. 29 19Laboratory research
Whole-animal estrogen activityUterus (estrogen response)Purified diosgenin at 20 to 200 mg/kg and a specified wild yam root extract at up to 500 mg/kg a day did not stimulate the rat uterus. 15 6Animal research
Cell membranes (detergent action)Not specifiedThe extract's saponins reduce surface tension and can break up cell membranes, which complicates cancer-cell tests. At non-killing levels it changed 346 genes, raising inflammation and steroid-making signals and lowering cell-division genes. 14Laboratory research
DNA methylation in breast cancer cellsGATA3, DNMTs, TET enzymesThe extract changed methylation patterns differently in estrogen-receptor positive and negative cell lines. 2Laboratory research
Kidney scarring pathwayTGF-beta1, NF-kappaB, CTGFRaised in rat kidney after 28 days of the extract. 27Animal research
Pain and inflammationNot specifiedThe extract reduced pain behaviour and white-cell migration in mice. 12Animal research
Drug-metabolising enzymes and transportersCYP3A4; P-glycoproteinDiosgenin and dioscin inhibited CYP3A4; diosgenin was pumped out of gut-model cells by P-glycoprotein. 13Laboratory research

Absorption, metabolism and elimination

Absorption
No human absorption data found. In a gut-cell model dioscin crossed the barrier better than diosgenin, which was pushed back out by P-glycoprotein. A diosgenin study in mice (cited by the cognition-trial authors) found an oil solvent gave the best blood and brain levels, which is why the trial extract was made in olive oil.
Distribution
Not found in people.
Metabolism
In lab tests dioscin partly turns into diosgenin in simulated stomach (24.2%) and gut (2.4%) fluid. Diosgenin was stable in human liver microsomes (no phase I metabolism) but disappeared in the S9 fraction with a half-life of 11.3 minutes, pointing to phase II metabolism. Nothing in these tests shows diosgenin turning into progesterone.
Elimination
Not found.
Bioavailability
Not found in people.

13 25

Isolated compounds versus whole extracts

Isolated diosgenin, the whole root extract and the cosmetic extract behave differently. Purified diosgenin did not stimulate the rat uterus, while the whole extract acted as a weak phytoestrogen in breast cancer cells, and the extract also carries detergent-like saponins that purified diosgenin does not. Results for one cannot be applied to another, and none of these lab results show what happens in people.

Nutritional composition

Wild yam root is used as a medicine, not a staple food. Studies of food yam (Dioscorea alata) as a large share of daily meals involve a different species and a very large food amount, so they say nothing about wild yam supplements.

10benefits and uses looked at
30studies and sources checked
Low certaintybest evidence rating found
7lab markers tracked in trials

1 mixed findings3 low certainty1 very low certainty4 not enough evidence1 evidence against

What was looked at

The 10 benefits and uses checked for Wild yam, each with how strong the evidence is. Tap one to open it.

Lab markers tracked in the studies

Estradiol and FSH (menopause hormone markers)Progesterone (blood and saliva)Greene Climacteric Scale (menopause symptom score)RBANS total score (thinking test)Total cholesterolProstaglandin E2 and COX-2 (inflammation chemicals)Urinary isoprostanes (oxidative stress marker)

What is Wild yam good for?

The main proposed uses and how strong the human evidence is for each. "Low" means small or limited studies. "Insufficient" means only lab or animal work. Other yam species are named where they were used.

Menopause symptoms: wild yam creamLow certaintyThe one controlled trial of a wild yam cream (23 women, 3 months) found no difference from placebo cream. Hot flushes improved a little with both. Hormones, cholesterol and blood pressure did not change. Two reviews did not find consistent evidence for wild yam. Menopause symptoms: oral yam (Dioscorea alata, a different species)Low certaintyA 12-month trial of 50 women found fewer symptoms than placebo with an extract of Dioscorea alata, especially anxiety, tension and sleep. A one-arm food study changed hormone markers. Neither used wild yam, so the results cannot be assumed for it. The claim that wild yam turns into progesteroneEvidence againstDrug makers turn diosgenin into hormones in the lab, but there is no evidence the human body does this. In the cream trial, progesterone did not change. A wild yam product should not replace prescribed progesterone. Thinking skillsLow certaintyOne small crossover trial (28 healthy adults, 12 weeks) found a higher score on a thinking test with a diosgenin-rich yam extract. The yam species was not stated and the trial has not been repeated. Cholesterol and blood fatsMixed findingsHeavy daily eating of Dioscorea alata food yam lowered cholesterol 5.9% in a one-arm study with no placebo group. The wild yam cream showed no change in cholesterol, triglycerides or HDL. Period pain and PMS (another yam, Dioscorea esculenta)Very low certaintyA 10-woman crossover trial found lower pain and PMS scores and lower inflammation chemicals with powder of a different yam species. Too small to rely on. Blood sugarNot enough evidenceA systematic review found ten rodent studies of various yams, all showing better blood sugar. No human trial was found, and none is specific to wild yam. Joint pain and inflammationNot enough evidenceTraditional use for joint pain and rheumatoid arthritis. A mouse study found lower pain responses and white-cell movement. No human trial was found. Bone health after menopauseNot enough evidenceOnly lab results in bone cells and a review sentence that more evidence is needed. No human bone trial was found. Cancer cells in the lab (not a treatment)Not enough evidenceWild yam extract slowed breast cancer cells in dishes, partly through detergent-like saponins that burst cells. This does not show it prevents or treats cancer.

Benefits, one by one

Each card is a research question, not a promise. Tap a goal to filter. Open a card to see the studies, doses and limits.

Menopause symptoms: wild yam cream on the skin

Low certainty

In the one controlled trial of a wild yam cream, women with menopause symptoms did no better on the wild yam cream than on a matching placebo cream. Hot flushes eased a little with both, so the improvement looks like a placebo effect.

4 studiesCream applied to the skin; strength and diosgenin content not stated …

Studies, doses and limits

What the trials found

One double-blind, placebo-controlled crossover trial (Komesaroff 2001, 23 healthy women with troublesome menopause symptoms) gave active wild yam (D. villosa) cream and matching placebo for 3 months each, in random order. Both creams brought a minor improvement in flushing and other symptoms, with no statistical difference between them. Hormones, blood fats, glucose and blood pressure did not change. Two review articles that included wild yam (Kelley 2010; Depypere 2014) did not find consistent evidence for it. MSK's clinical summary calls the topical D. villosa formula ineffective.

Results

No difference from placebo on flushing, other symptoms, lipids, FSH, estradiol or progesterone after 3 months.

Effect sizes as reported

No effect sizes in the abstract; the reported finding is no statistical difference between active and placebo cream.

Why this rating

Only one small crossover trial (23 women) tested a wild yam cream. It was null, and a null result from a small trial cannot rule out a small effect.

Form and dose studied

Cream applied to the skin; strength and diosgenin content not stated in the abstract.

Who was studied

Healthy women about 4 years after their last period, average age 53.

Limits

Small, short, one cream, one site; no longer follow-up; funding not stated in the abstract.

Why researchers looked

Wild yam creams are sold as a gentle alternative to hormone therapy for hot flushes and night sweats. The trial's authors noted that no safety or efficacy study had been done before theirs.

Traditional use

Wild yam root is used in herbal medicine for menopause symptoms, stomach and gut problems, muscle spasm, asthma and joint pain (clinical summary, MSK).

Proposed mechanism Preliminary mechanism

The root contains diosgenin and related saponins that are claimed to influence the body's own hormone production. Lab work shows weak estrogen-like activity (see the hormones section), but the one human trial found no change in estradiol, FSH or progesterone.

A proposed mechanism does not show that the effect happens in people.

No significant side effects with either cream over 3 months.

11 10 7 16

Menopause symptoms: oral yam products (a different species, Dioscorea alata)

Low certainty

A 12-month trial of an oral extract of another yam species (Dioscorea alata) found fewer menopause symptoms than placebo, especially anxiety and sleep problems. This is not wild yam, so it cannot be taken as proof for wild yam.

3 studiesHsu 2011: extract in sachets, 12 mg per sachet, two a day for 12 mont…

Studies, doses and limits

What the trials found

Hsu 2011 was a two-centre, randomized, double-blind, placebo-controlled trial of 50 menopausal women given D. alata extract or placebo for 12 months. The total Greene Climacteric Scale score fell significantly with the extract (p < 0.01), with the clearest gains in feeling tense or nervous (p = 0.007), insomnia (p = 0.004), excitable (p = 0.047) and musculoskeletal pain (p = 0.019). Safety monitoring found no problems. A separate one-arm 30-day study (Wu 2005) had 22 postmenopausal women replace much of their rice with 390 g a day of D. alata food yam; blood estrone and SHBG rose and urinary markers changed, but there was no placebo group. MSK's summary calls the evidence on oral yam mixed and limited.

Results

Lower Greene scale scores than placebo after 12 months with a D. alata extract. Hormone markers shifted in the one-arm food study.

Effect sizes as reported

p < 0.01 for total Greene score; p-values for single items as above. No effect sizes or intervals in the abstracts.

Why this rating

One 50-woman placebo-controlled trial and one uncontrolled study, both with D. alata, not wild yam. Abstracts give no effect sizes.

Form and dose studied

Hsu 2011: extract in sachets, 12 mg per sachet, two a day for 12 months. Wu 2005: 390 g of cooked yam in 2 of 3 meals for 30 days.

Who was studied

Menopausal and postmenopausal women in Taiwan.

Limits

Different species; small; the food-yam study had no placebo; results may not apply to wild yam root products.

Why researchers looked

Researchers in Taiwan tested whether a yam used in folk medicine for menopause could ease symptoms and change hormone levels.

Traditional use

Yam (Dioscorea) has been used folklorically for menopausal symptoms (Wu 2005).

Proposed mechanism Preliminary mechanism

Not established. Steroid-like plant compounds could act weakly like hormones, but the trials did not test a mechanism.

A proposed mechanism does not show that the effect happens in people.

No safety signals were reported in either study, but they were small. Hormone changes seen in the food study mean the same caution applies to people with hormone-sensitive conditions.

9 28 16

The claim: the body turns wild yam into progesterone

Evidence against

No. Wild yam creams and pills are often sold as 'natural progesterone'. Drug makers do use diosgenin from yams as a starting material, but only in a laboratory process. There is no evidence that the human body can make that change, and in the one trial that measured it, progesterone did not rise.

5 studiesNot applicable.

Studies, doses and limits

What the trials found

MSK's clinical summary says diosgenin from wild yam has been used as raw material for synthetic progesterone, but there is no evidence the human body can convert diosgenin into progesterone. In the wild yam cream trial (Komesaroff 2001) serum and salivary progesterone, estradiol and FSH did not change after 3 months. Zava 1998 tested saliva receptor-binding after people consumed soy milk, progesterone, medroxyprogesterone or 'wild Mexican yam products containing diosgenin', but the abstract does not report the yam result, so it cannot be used either way. Lab studies show wild yam extract has weak estrogen-like activity in breast cancer cells (Park 2009), which is a different thing from making progesterone.

Results

No rise in progesterone in the one trial that measured it; no source read shows conversion in the human body.

Why this rating

An authoritative clinical summary says there is no evidence of conversion in humans, and the one measuring trial showed no rise in progesterone. This is a rating on the claim, not on wild yam as a whole.

Who was studied

Menopausal women in the trial; lab studies.

Limits

Only one human trial measured progesterone, in 23 women with one cream; a different product could in theory differ, but no source read shows one that does.

Why researchers looked

Marketing for wild yam products says diosgenin is changed into progesterone or DHEA in the body, so a cream or pill acts as 'natural hormone replacement'. This is the claim readers most often ask about.

Traditional use

Not traditional. The claim comes from the history of the pharmaceutical industry using diosgenin from yams as a raw material for synthetic steroid hormones.

Proposed mechanism Pharmacological theory

The chemistry is done in factories, not in the body. MSK states there is no evidence the human body can convert diosgenin into progesterone. In lab tests, the dioscin in the root partly turns into diosgenin in simulated stomach and gut fluid, but nothing in that study shows diosgenin turning into a hormone.

A proposed mechanism does not show that the effect happens in people.

Because the claim is wrong, a wild yam cream should not be used in place of prescribed progesterone, for example to protect the womb lining during estrogen therapy. Ask a doctor.

16 11 30 19 13

Thinking skills (a diosgenin-rich yam extract)

Low certainty

One small Japanese trial of healthy adults found better scores on a thinking test after 12 weeks of a diosgenin-rich yam extract. It is a single small trial with an unnamed yam species, so it is only a first signal.

2 studiesExtract in olive oil soft capsules; dose not stated in the abstract.

Studies, doses and limits

What the trials found

Tohda 2017 was a placebo-controlled, randomized, double-blind crossover trial of 28 healthy adults aged 20 to 81. A diosgenin-rich yam extract in olive-oil soft capsules for 12 weeks (with a 6-week washout) raised the total RBANS score; semantic fluency was the one subtest with a significant gain. No adverse effects were reported. The abstract does not name the yam species or the dose. A review article (Semwal 2022) mentions promising effects on cognitive function but says better trials are needed.

Results

Higher total RBANS score than placebo; better semantic fluency.

Effect sizes as reported

Numbers not in the abstract.

Why this rating

One small crossover trial in healthy people, species and dose unstated, no replication found.

Form and dose studied

Extract in olive oil soft capsules; dose not stated in the abstract.

Who was studied

Healthy adults, 20 to 81 years.

Limits

Small, short; healthy people so no information about memory loss; species not stated, so it cannot be assumed to be D. villosa.

Why researchers looked

In mice, diosgenin helped repair damaged nerve fibres and improved memory in an Alzheimer's model, so the researchers tested it in people.

Proposed mechanism Animal research

The authors report that in mice diosgenin repaired axon and synapse damage and improved memory. Animal evidence; not shown in people.

A proposed mechanism does not show that the effect happens in people.

No adverse effects reported in the trial.

25 24

Menstrual pain and PMS (a different yam, Dioscorea esculenta)

Very low certainty

A tiny trial in 10 young women found less period pain and PMS symptoms after a month of powder from another yam, Dioscorea esculenta. It is too small to rely on, and it is not wild yam.

1 studies300 mg a day of powder for 4 weeks.

Studies, doses and limits

What the trials found

Sato 2024 was a randomized, double-blind, placebo-controlled crossover trial in 10 healthy young women given D. esculenta powder (300 mg a day) or placebo for 4 weeks each, with a 4-week washout. PGE2 and COX-2 were lower after the yam (p = 0.038, p = 0.042) and pain and PMS scores were lower (p = 0.046, p = 0.035).

Results

Lower PGE2, COX-2, pain and PMS scores than placebo.

Effect sizes as reported

p-values only.

Why this rating

Ten participants, one trial, a different species, no replication.

Form and dose studied

300 mg a day of powder for 4 weeks.

Who was studied

Healthy young women in Japan.

Limits

Very small; short; different species; results may be chance.

Why researchers looked

Diosgenin lowered prostaglandin E2 (a pain and inflammation chemical) in rodents, so researchers tested a yam powder against period pain.

Proposed mechanism Preliminary mechanism

Lowering prostaglandin E2 and COX-2, the same pathway targeted by common period-pain tablets, was suggested by the trial's lab measurements.

A proposed mechanism does not show that the effect happens in people.

No safety findings in the abstract.

23

Cholesterol and blood fats

Mixed findings

Results are mixed. Eating a lot of food yam lowered cholesterol a little in a small uncontrolled study, but the wild yam cream trial saw no change in cholesterol, triglycerides or HDL.

2 studiesFood yam eaten in large amounts; or cream on the skin.

Studies, doses and limits

What the trials found

The 30-day one-arm food study (Wu 2005, D. alata, 390 g a day) found plasma cholesterol fell 5.9%. The wild yam cream trial (Komesaroff 2001) found no change in total cholesterol, triglycerides or HDL after 3 months.

Results

A 5.9% cholesterol fall with a large daily amount of D. alata food; no change with D. villosa cream.

Effect sizes as reported

Cholesterol -5.9% (Wu 2005); no change (Komesaroff 2001).

Why this rating

Two small studies pointing different ways, with different products and species.

Form and dose studied

Food yam eaten in large amounts; or cream on the skin.

Who was studied

Postmenopausal women.

Limits

No placebo in the food study; very different products.

Why researchers looked

Diosgenin and yam foods lowered cholesterol in animals, so lipids were measured in the menopause trials.

Proposed mechanism Animal research

Not shown in people. Animal work suggests diosgenin affects cholesterol uptake and handling.

A proposed mechanism does not show that the effect happens in people.

None.

28 11

Blood sugar

Not enough evidence

All the evidence is from rodents and covers many yam species and compounds. No human trial was found, and nothing is specific to wild yam.

2 studiesNot applicable.

Studies, doses and limits

What the trials found

A systematic review (Alharazi 2022) found ten rodent studies and no human studies. All ten showed better blood sugar control with yam or extracts (dioscin, dioscorin, diosgenin and others). The authors say human trials are needed.

Results

Better glucose control in rodent diabetes models.

Effect sizes as reported

No pooled effect size.

Why this rating

Animal data only; no human trials; not specific to wild yam.

Who was studied

Rodent models.

Limits

Animal studies; many species and compounds mixed together.

Why researchers looked

Yam species are eaten in many countries and some have lowered blood sugar in animals.

Traditional use

Yams are used for diabetes in Asian traditional medicine (genus review).

Proposed mechanism Animal research

Not established; the review says the molecular mechanism remains largely unknown.

A proposed mechanism does not show that the effect happens in people.

Anyone taking diabetes medicines should ask a doctor first, since an effect on blood sugar is claimed, though not tested in people with wild yam.

1 26

Pain and inflammation (joints, arthritis)

Not enough evidence

Wild yam is used traditionally for joint pain and rheumatoid arthritis. A rodent study found pain- and inflammation-lowering effects, but no human trial of this use was found.

2 studiesNot applicable.

Studies, doses and limits

Results

In mice, doses of 200 and 400 mg/kg reduced acetic-acid writhing and inflammatory pain, and 100 to 400 mg/kg reduced white-cell migration (Lima 2013).

Effect sizes as reported

p < 0.0001 for writhing and inflammatory pain at 200 and 400 mg/kg.

Why this rating

Mouse data only.

Who was studied

Mice.

Limits

Rodents; pain tests; no joint-disease model.

Why researchers looked

Folk use for joint pain and rheumatoid arthritis, including in Brazil.

Traditional use

Used for joint pain and rheumatoid arthritis (Lima 2013; MSK summary).

Proposed mechanism Animal research

The extract reduced white-cell movement to an inflamed area in mice; detail beyond that was not tested.

A proposed mechanism does not show that the effect happens in people.

See the kidney finding in rats on the safety tab before long-term use.

12 16

Bone health after menopause

Not enough evidence

A 2014 review says animal and human studies suggest wild yam may protect against osteoporosis, but that more evidence is needed. The abstract does not name any human bone trial, so this is not usable evidence for bone.

2 studiesNot applicable.

Studies, doses and limits

Results

Cell-culture signals only.

Why this rating

Lab data and a review statement; no human bone trial found.

Who was studied

Cells.

Limits

Purified diosgenin in mouse cells.

Why researchers looked

Diosgenin has estrogen-like activity in bone cells in the lab.

Proposed mechanism Laboratory research

In mouse bone-forming cells diosgenin raised VEGF-A through estrogen receptor signals and displaced estradiol from the receptor (IC50 10 nM).

A proposed mechanism does not show that the effect happens in people.

The estrogen-receptor binding means the same caution as for any estrogen-like product.

29 7

Cancer cells in the lab (not a treatment)

Not enough evidence

Wild yam extract killed or slowed breast cancer cells in dishes. That is not evidence that it prevents or treats cancer, and the extract contains detergent-like saponins that break up cell membranes.

4 studiesNot applicable.

Studies, doses and limits

Results

Reduced cell viability; gene changes (GATA3, cell-division genes); weak estrogen-like gene activity in MCF-7 cells.

Effect sizes as reported

346 genes changed of 48,226 tested (Mazzio 2021).

Why this rating

Cell-culture work only.

Who was studied

Cell lines.

Limits

Dish studies; concentrations that kill cells are not reached by taking a supplement.

Why researchers looked

Steroid-like plant compounds can interact with hormone receptors on breast cancer cells.

Proposed mechanism Laboratory research

Extract lowered viability of breast cancer cell lines and changed methylation and gene activity; the detergent action of saponins is a confounding factor.

A proposed mechanism does not show that the effect happens in people.

Some of the same lab work shows estrogen-like activity, which is why people with hormone-sensitive cancers are told to talk to a doctor first.

2 14 19 16

Connections to the rest of health

How Wild yam connects to the rest of our health knowledge graph. Every link says what kind of connection it is. A safety link (for example to the liver) is a warning, not a benefit. A study that merely mentions a topic never creates a benefit link.

Explore every connection: goals, body systems, organs, symptoms, genes

A. Wellness goals

Connected toKind of connectionEvidence statusContextStudies
Menopause support Potential benefit Low certainty The wild yam cream did no better than placebo; the better oral results used another species. Menopause symptoms: wild yam cream on the skin: In the one controlled trial of a wild yam cream, women with menopause symptoms did no better on the wild yam cream than on a matching placebo cream. Hot flushes eased a little with both, so the improvement looks like a placebo effect.
Preparation or compound: Wild yam cream (no benefit over placebo); Dioscorea alata oral extract (benefit)
11 9 10 7 16 28
Memory support Potential benefit Low certainty One small crossover trial in healthy adults. Thinking skills (a diosgenin-rich yam extract): One small Japanese trial of healthy adults found better scores on a thinking test after 12 weeks of a diosgenin-rich yam extract. It is a single small trial with an unnamed yam species, so it is only a first signal.
Preparation or compound: Diosgenin-rich yam extract
25 24
Hormone balance Biological association Evidence against No evidence the body converts diosgenin into progesterone. The claim: the body turns wild yam into progesterone: No. Wild yam creams and pills are often sold as 'natural progesterone'. Drug makers do use diosgenin from yams as a starting material, but only in a laboratory process. There is no evidence that the human body can make that change, and in the one trial that measured it, progesterone did not rise.
Preparation or compound: Wild yam as a source of progesterone
16 11 30 19 13
Womens Wellness Potential benefit Low certainty Menopause symptoms: wild yam cream on the skin: In the one controlled trial of a wild yam cream, women with menopause symptoms did no better on the wild yam cream than on a matching placebo cream. Hot flushes eased a little with both, so the improvement looks like a placebo effect. Menopause symptoms: oral yam products (a different species, Dioscorea alata): A 12-month trial of an oral extract of another yam species (Dioscorea alata) found fewer menopause symptoms than placebo, especially anxiety and sleep problems. This is not wild yam, so it cannot be taken as proof for wild yam. 11 10 7 16 9 28 23
Hormone Balance Potential benefit Low certainty Menopause symptoms: wild yam cream on the skin: In the one controlled trial of a wild yam cream, women with menopause symptoms did no better on the wild yam cream than on a matching placebo cream. Hot flushes eased a little with both, so the improvement looks like a placebo effect. 11 10 7 16
Anxiety Support Potential benefit Low certainty Menopause symptoms: oral yam products (a different species, Dioscorea alata): A 12-month trial of an oral extract of another yam species (Dioscorea alata) found fewer menopause symptoms than placebo, especially anxiety and sleep problems. This is not wild yam, so it cannot be taken as proof for wild yam. 9 28 16
Better Sleep Potential benefit Low certainty Menopause symptoms: oral yam products (a different species, Dioscorea alata): A 12-month trial of an oral extract of another yam species (Dioscorea alata) found fewer menopause symptoms than placebo, especially anxiety and sleep problems. This is not wild yam, so it cannot be taken as proof for wild yam. 9 28 16
Menopause Support Biological association Evidence against The claim: the body turns wild yam into progesterone: No. Wild yam creams and pills are often sold as 'natural progesterone'. Drug makers do use diosgenin from yams as a starting material, but only in a laboratory process. There is no evidence that the human body can make that change, and in the one trial that measured it, progesterone did not rise. 16 11 30 19 13
Womens Wellness Biological association Evidence against The claim: the body turns wild yam into progesterone: No. Wild yam creams and pills are often sold as 'natural progesterone'. Drug makers do use diosgenin from yams as a starting material, but only in a laboratory process. There is no evidence that the human body can make that change, and in the one trial that measured it, progesterone did not rise. 16 11 30 19 13
Cognitive Performance Potential benefit Low certainty Thinking skills (a diosgenin-rich yam extract): One small Japanese trial of healthy adults found better scores on a thinking test after 12 weeks of a diosgenin-rich yam extract. It is a single small trial with an unnamed yam species, so it is only a first signal. 25 24
Brain Health Potential benefit Low certainty Thinking skills (a diosgenin-rich yam extract): One small Japanese trial of healthy adults found better scores on a thinking test after 12 weeks of a diosgenin-rich yam extract. It is a single small trial with an unnamed yam species, so it is only a first signal. 25 24
Inflammation Balance Potential benefit Very low certainty Menstrual pain and PMS (a different yam, Dioscorea esculenta): A tiny trial in 10 young women found less period pain and PMS symptoms after a month of powder from another yam, Dioscorea esculenta. It is too small to rely on, and it is not wild yam. 23
Cholesterol Balance Potential benefit Mixed findings Cholesterol and blood fats: Results are mixed. Eating a lot of food yam lowered cholesterol a little in a small uncontrolled study, but the wild yam cream trial saw no change in cholesterol, triglycerides or HDL. 28 11
Heart Health Potential benefit Mixed findings Cholesterol and blood fats: Results are mixed. Eating a lot of food yam lowered cholesterol a little in a small uncontrolled study, but the wild yam cream trial saw no change in cholesterol, triglycerides or HDL. 28 11
Blood Sugar Balance Preliminary mechanism Not enough evidence Blood sugar: All the evidence is from rodents and covers many yam species and compounds. No human trial was found, and nothing is specific to wild yam. 1 26
Metabolic Health Preliminary mechanism Not enough evidence Blood sugar: All the evidence is from rodents and covers many yam species and compounds. No human trial was found, and nothing is specific to wild yam. 1 26
Joint Support Traditional use Not enough evidence Pain and inflammation (joints, arthritis): Wild yam is used traditionally for joint pain and rheumatoid arthritis. A rodent study found pain- and inflammation-lowering effects, but no human trial of this use was found. 12 16
Inflammation Balance Traditional use Not enough evidence Pain and inflammation (joints, arthritis): Wild yam is used traditionally for joint pain and rheumatoid arthritis. A rodent study found pain- and inflammation-lowering effects, but no human trial of this use was found. 12 16
Healthy Aging Preliminary mechanism Not enough evidence Bone health after menopause: A 2014 review says animal and human studies suggest wild yam may protect against osteoporosis, but that more evidence is needed. The abstract does not name any human bone trial, so this is not usable evidence for bone. 29 7
Menopause Support Preliminary mechanism Not enough evidence Bone health after menopause: A 2014 review says animal and human studies suggest wild yam may protect against osteoporosis, but that more evidence is needed. The abstract does not name any human bone trial, so this is not usable evidence for bone. 29 7

B. Body systems

Connected toKind of connectionEvidence statusContextStudies
Reproductive System Biological association Low certainty Studied for: Menopause symptoms: wild yam cream on the skin Studied for: Menopause symptoms: oral yam products (a different species, Dioscorea alata) 11 10 7 16 9 28 30 19 13 23 2 14
Endocrine System Biological association Low certainty Studied for: Menopause symptoms: wild yam cream on the skin Studied for: The claim: the body turns wild yam into progesterone 11 10 7 16 30 19 13 1 26
Nervous System Biological association Low certainty Studied for: Menopause symptoms: oral yam products (a different species, Dioscorea alata) Studied for: Thinking skills (a diosgenin-rich yam extract) 9 28 16 25 24
Cardiovascular System Biological association Mixed findings Studied for: Cholesterol and blood fats 28 11
Metabolism Weight Biological association Not enough evidence Studied for: Blood sugar 1 26
Musculoskeletal System Biological association Not enough evidence Studied for: Pain and inflammation (joints, arthritis) Studied for: Bone health after menopause 12 16 29 7

C. Body parts and organs

Connected toKind of connectionEvidence statusContextStudies
Reproductive organs Contraindication Not enough evidence Weak estrogen-like activity in cells; people with hormone-sensitive cancers are advised to ask a doctor first. Weak estrogen-like activity in cells; caution with hormone-sensitive cancers.
Preparation or compound: Wild yam extract and diosgenin
19 29 16
Kidneys Adverse effect or risk Very low certainty Kidney scarring and inflammation markers rose in rats. Kidney scarring markers rose in rats.
Preparation or compound: Dioscorea villosa rhizome extract (rats, 28 days)
27
Adrenal glands Adverse effect or risk Very low certainty Smaller adrenal cortex and medulla in rats.
Preparation or compound: Diosgenin delivered by implant (rats)
5
Liver Drug or supplement interaction Very low certainty Inhibited CYP3A4 in human liver assays.
Preparation or compound: Diosgenin and dioscin
13

I. Biomarkers

Connected toKind of connectionEvidence statusContextStudies
Estradiol and FSH (menopause hormone markers) Biological association Low certainty Measured in trials: no-change. A lab change is not the same as a health benefit. 11 28
Progesterone (blood and saliva) Biological association Low certainty Measured in trials: no-change. A lab change is not the same as a health benefit. 11 16
Greene Climacteric Scale (menopause symptom score) Biological association Low certainty Measured in trials: lowered. A lab change is not the same as a health benefit. 9
RBANS total score (thinking test) Biological association Low certainty Measured in trials: raised. A lab change is not the same as a health benefit. 25
Total cholesterol Biological association Mixed findings Measured in trials: mixed. A lab change is not the same as a health benefit. 28 11
Prostaglandin E2 and COX-2 (inflammation chemicals) Biological association Very low certainty Measured in trials: lowered. A lab change is not the same as a health benefit. 23
Urinary isoprostanes (oxidative stress marker) Biological association Very low certainty Measured in trials: lowered. A lab change is not the same as a health benefit. 28

J. Genes, receptors and enzymes

Connected toKind of connectionEvidence statusContextStudies
Estrogen receptor alpha and beta Preliminary mechanism In vitro Diosgenin binds in a lab assay; the extract lowers receptor alpha protein in MCF-7 cells 29 19
Progesterone receptor (PGR) and pS2 (TFF1) Preliminary mechanism In vitro mRNA raised by the extract in MCF-7 cells 19
GATA3 and DNA methyltransferases Preliminary mechanism In vitro Changed by the extract in breast cancer cell lines 2
CYP3A4 Preliminary mechanism In vitro Inhibited by diosgenin and dioscin in human liver assays 13

K. Biological pathways

Connected toKind of connectionEvidence statusContextStudies
TGF-beta1 / NF-kappaB kidney scarring Preliminary mechanism Animal Raised in rat kidney with the extract 27
Prostaglandin E2 / COX-2 Preliminary mechanism Human (other species) Lower after Dioscorea esculenta powder in a 10-woman trial 23

L. Active compounds

Connected toKind of connectionEvidence statusContextStudies
Diosgenin Biological association In vitro; animal Raw material for steroid drugs. Binds the estrogen receptor in a binding assay; no estrogen-like effect in a rat uterus test.
Preparation or compound: Rhizome
6 29 15 20
Dioscin Biological association In vitro Partly converts to diosgenin in simulated stomach and gut fluid; inhibits CYP3A4 in test tubes.
Preparation or compound: Rhizome
13 21
Dioscoreavilloside A and B, parvifloside Biological association Lab analysis Found only in D. villosa among the two species tested; useful as identity markers.
Preparation or compound: Rhizome
4
Total steroidal saponins and diosgenin in products Biological association Lab analysis Content differs widely between products.
Preparation or compound: Rhizome
3

Each connection is stored with the ingredient, the connected record, the kind of connection, the evidence status, the supporting studies, the preparation or compound involved, and a review date (last reviewed October 25, 2026).

Evidence at a glance: what changed in 7 lab markers

Tap a number to show only those markers. Counts are markers, not people.

The evidence

The research centre for Wild yam. Every record here was checked against PubMed or the publisher's page; we never list a study we have not verified.

Evidence by outcome

Bars show how many studies we found for each outcome, not how well it works. People are added up across trials only (reviews are not added, to avoid double counting).

How we rate evidence

High certainty

Several well-run trials or reviews agree; further research is unlikely to change the picture much.

Moderate certainty

Good trials point the same way, but some doubt remains.

Low certainty

Small, short or inconsistent trials. The finding could change with better research.

Very low certainty

Very little or very weak human data. Treat as a possibility only.

Mixed findings

Trials or reviews disagree with each other.

Not enough evidence

Not enough human research to say either way.

Evidence against

Good research found no benefit, or found harm.

We take the reviewers' own risk-of-bias and GRADE statements where they exist, and otherwise judge from study size, design, consistency, directness and whether a product matches what is sold. Many publications do not make evidence high. Method note: We searched PubMed, read the Memorial Sloan Kettering wild yam page, and checked the plant name in GBIF and NCBI Taxonomy and compounds in PubChem. Only abstracts were read for nearly all studies. Some sources were not verified: no EMA herbal monograph was found and the EMA site could not be checked; the NCCIH wild yam page returned 404; no LiverTox or LactMed entry was found; Commission E, WHO and FDA were not checked directly. Certainty ratings are the compiler's own reading, not formal grades. No study is cited that we could not verify.

Study library: every study we checked 30
StudyDesignPeopleProduct, dose, lengthResult
Alharazi 2022
Could consumption of yam (Dioscorea) or its extract be beneficial in controlling glycaemia: a systematic review.
Br J Nutr · PMID 34521490 · DOI
Systematic review
animal
10
Ten rodent studies of diabetes (no human studies met the criteria)
Yam (Dioscorea species) and extracts containing dioscin, dioscorin, diosgenin and other compounds
unspecified · vs Control animals
All 10 rodent studies showed better blood sugar control with yam or its extracts, often with changes in body weight and fat. The authors call for human trials.
All 10 included studies favoured yam in rodents.
Methods, limits and funding

Outcomes: Fasting blood glucose, glucose tolerance, insulin

Limitations: Animal studies only; many Dioscorea species and compounds; none specific to wild yam.

Funding and conflicts: No conflict stated in the abstract

Read: abstract

Aumsuwan 2015
Evaluation of wild yam (Dioscorea villosa) root extract as a potential epigenetic agent in breast cancer cells.
In Vitro Cell Dev Biol Anim · PMID 25148825 · DOI
Laboratory research
in-vitro
MCF-7 (estrogen-receptor positive) and MDA-MB-231 (negative) breast cancer cells Wild yam (Dioscorea villosa) root extract
root 0 to 50 micrograms/mL 72 hours · vs Untreated cells
The extract lowered the viability of both cell lines and raised GATA3 mRNA in a concentration-dependent way, with different DNA-methylation changes in the two cell types.
Concentration-dependent lowering of viability; no numbers in the abstract.
Methods, limits and funding

Outcomes: Cell viability, GATA3 gene, DNA methylation

Limitations: Cell-line study only; says nothing about use in people or about cancer prevention or treatment.

Funding and conflicts: No conflict stated in the abstract; some authors at a US NIH-funded centre

Read: abstract

Avula 2014
Chemical fingerprint analysis and quantitative determination of steroidal compounds from Dioscorea villosa, Dioscorea species and dietary supplements using UHPLC-ELSD.
Biomed Chromatogr · PMID 24019066 · DOI
Laboratory research
in-vitro
Dioscorea rhizomes and tubers and commercial dietary supplements Dioscorea villosa and other Dioscorea species; supplements
rhizome
Total standard compounds ranged from 0.01% to 14.5% in dry plant material and from 0.9 to 28.6 mg per daily intake in solid commercial products.
Content varied about 30-fold between supplements (0.9 to 28.6 mg per daily intake).
Methods, limits and funding

Outcomes: Amount of steroidal saponins and diosgenin

Limitations: Quality-control method paper; does not say which products were wild yam only.

Funding and conflicts: No conflict declared

Read: abstract

Avula 2014
Characterization of steroidal saponins from Dioscorea villosa and D. cayenensis using ultrahigh performance liquid chromatography/electrospray ionization quadrupole time-of-flight mass spectrometry.
Planta Med · PMID 24510365 · DOI
Laboratory research
in-vitro
Dried rhizomes of two Dioscorea species and dietary supplements Dioscorea villosa and Dioscorea cayenensis rhizomes
rhizome
21 saponins were detected. Some are found only in one species: asperin and gracillin only in D. cayenensis; dioscoreavilloside A and B and parvifloside only in D. villosa. The method can show whether D. villosa is present in a product and can help catch mislabelling or spiking.
Species-specific saponin markers found.
Methods, limits and funding

Outcomes: Identification of saponins; ability to tell the species apart in products

Limitations: Lab method paper. The abstract does not say how many products were mislabelled.

Funding and conflicts: No conflict declared

Read: abstract

Benghuzzi 2003
The effects of sustained delivery of diosgenin on the adrenal gland of female rats.
Biomed Sci Instrum · PMID 12724916
Animal research
animal
Adult female rats (ovariectomised and control) Diosgenin from wild yam root, delivered continuously by an implant
isolated compound 500 mg loaded in a slow-release implant 45 days · vs Control and ovariectomised rats without diosgenin
Ovariectomised rats had bigger adrenal areas; diosgenin-treated rats had a significant decrease in cortical and medullary adrenal areas (p < 0.001). The authors say reduced adrenal mass could pose a risk of major endocrine problems.
Adrenal areas significantly smaller with diosgenin (p < 0.001).
Methods, limits and funding

Outcomes: Body, organ and adrenal gland weight and tissue changes

Limitations: Rats; implanted purified diosgenin; not oral wild yam.

Funding and conflicts: Not stated in the abstract

Read: abstract

Cosmetic Ingredient Review Expert Panel (no authors listed) 2004
Final report of the amended safety assessment of Dioscorea Villosa (Wild Yam) root extract.
Int J Toxicol · PMID 15513824 · DOI
Systematic review
animal
Safety assessment of one specified cosmetic wild yam root extract (animal and lab tests) Dioscorea villosa root extract, made with a specified process (saponins up to 0.4%, diosgenin up to 3.5%)
rhizome Cosmetic use up to 15% of the extract (0.5% plant solids)
One of ten rats died at 2 g/kg by mouth; none at 0.5 g/kg. No significant harm in a 28-day skin study at up to 10%. Undiluted extract irritated rabbit skin; 10% did not. No sensitization in guinea pigs. No estrogen-like effect in a juvenile rat uterus test at up to 500 mg/kg a day. Gene-damage tests were negative except one Ames test strain at one dose with one method. Panel concluded safe as used in cosmetics, only for extracts with a similar chemical profile; it flagged possible estrogen-like or progesterone-like activity as the main concern and urged limits on pesticide residues.
Safe as used in cosmetics, for the extract described.
Methods, limits and funding

Outcomes: Acute and short-term toxicity, skin and eye irritation, sensitization, uterotrophic assay, genotoxicity

Limitations: Covers one specific extract and cosmetic use. Not a trial in people. The Cosmetic Ingredient Review is an industry-supported body.

Funding and conflicts: Industry-supported review body (Cosmetic Ingredient Review)

Read: abstract

Depypere 2014
Herbal preparations for the menopause: beyond isoflavones and black cohosh.
Maturitas · PMID 24314619 · DOI
Review
Mini-review of herbal products for menopause Herbal preparations including Dioscorea villosa
unspecified
The authors say animal and human studies suggest wild yam may protect against osteoporosis and breast and gynaecological cancers, but that further evidence is required.
Narrative statement; no numbers.
Methods, limits and funding

Outcomes: Efficacy and safety of herbs for menopause

Limitations: Mini-review; the abstract does not say which human studies it used. Treated here as low-weight.

Funding and conflicts: Not stated in the abstract

Read: abstract

GBIF 2026
GBIF backbone match: Dioscorea villosa L. (ACCEPTED, key 2754553)
GBIF API · Source
Authoritative guidance
Not applicable Dioscorea villosa
unspecified
Accepted name Dioscorea villosa L., family Dioscoreaceae, order Dioscoreales, class Liliopsida (exact match).
Methods, limits and funding

Outcomes: Reference record

Limitations: Single database check.

Read: summary-only

Hsu 2011
The assessment of efficacy of Diascorea alata for menopausal symptom treatment in Taiwanese women.
Climacteric · PMID 20653397 · DOI
Controlled trial
50
Menopausal women in two centres in Taiwan
Dioscorea alata (a different yam species, not wild yam) extract, oral
unspecified Two sachets a day, 12 mg per sachet 12 months · vs Placebo
Total Greene score fell significantly with the extract at 12 months (p < 0.01), more for anxiety than other items. Feeling tense or nervous (p = 0.007), insomnia (p = 0.004), excitable (p = 0.047) and musculoskeletal pain (p = 0.019) improved. Hormone profile changed in a positive direction according to the authors. Safety monitoring found no problems over 12 months.
Greene score lower than placebo at 12 months (p < 0.01); no effect size or interval in the abstract.
Methods, limits and funding

Outcomes: Greene Climacteric Scale; plasma hormone profile; safety monitoring

Limitations: Different species (D. alata). Small. Extract details and funding not in the abstract. Hormone results not given as numbers in the abstract.

Funding and conflicts: Not stated in the abstract

Read: abstract

Kelley 2010
Evaluating the evidence for over-the-counter alternatives for relief of hot flashes in menopausal women.
J Am Pharm Assoc · PMID 20833608 · DOI
Systematic review
Menopausal women; clinical trials of single-ingredient products including wild yam Single-ingredient OTC products including wild yam
unspecified Literature to June 2010 · vs Placebo or active treatment
The authors found conflicting results and concluded the evidence does not support alternative OTC therapies for hot flashes, and that long-term safety data are lacking for all of them.
Narrative review.
Methods, limits and funding

Outcomes: Hot flash (vasomotor) symptoms

Limitations: Search only to 2010; the abstract does not separate wild yam from the other products.

Funding and conflicts: Not stated in the abstract

Read: abstract

Komesaroff 2001
Effects of wild yam extract on menopausal symptoms, lipids and sex hormones in healthy menopausal women.
Climacteric · PMID 11428178
Controlled trial
23
Healthy women with troublesome menopausal symptoms, average age 53.3
Wild yam (Dioscorea villosa) extract, topical cream
rhizome extract (cream) Cream applied to the skin (amount not stated in the abstract) 3 months of active cream and 3 months of matching placebo, in random order, after a 4-week baseline · vs Matching placebo cream
No significant side effects. No change in weight, blood pressure, cholesterol, triglycerides, HDL, FSH, glucose, estradiol, or serum or salivary progesterone. Flushing and other symptoms improved a little with both placebo and active cream, with no statistical difference between them.
No difference between wild yam cream and placebo on symptoms or hormones.
Methods, limits and funding

Outcomes: Hot flush number and severity, other menopausal symptoms, lipids, FSH, glucose, estradiol, serum and salivary progesterone

Limitations: Small (23 women); crossover; short; cream strength and diosgenin content not given in the abstract.

Funding and conflicts: Not stated in the abstract

Read: abstract

Lima 2013
Bioassay-guided evaluation of Dioscorea villosa - an acute and subchronic toxicity, antinociceptive and anti-inflammatory approach.
BMC Complement Altern Med · PMID 23889998 · DOI
Animal research
animal
Mice and rats Dioscorea villosa dry extract (diosgenin the main compound), by mouth
unspecified 100 to 400 mg/kg for pain and inflammation tests; 5 g/kg once and 1 g/kg a day for 30 days for toxicity Single dose, or 30 days · vs Vehicle
At 200 and 400 mg/kg the extract reduced writhing and inflammatory pain, and at 100 to 400 mg/kg it reduced white-cell migration. Blood, chemistry and tissue results from the single and 30-day dosing showed only unremarkable changes.
p < 0.0001 for writhing and inflammatory pain at 200 and 400 mg/kg.
Methods, limits and funding

Outcomes: Pain (writhing, formalin), white-cell movement; blood tests and tissue exam

Limitations: Rodents only. Short. Pain tests do not show benefit in joint disease in people.

Funding and conflicts: Not stated in the abstract

Read: abstract

Manda 2013
Characterization of in vitro ADME properties of diosgenin and dioscin from Dioscorea villosa.
Planta Med · PMID 23970424 · DOI
Laboratory research
in-vitro
Lab tests: simulated stomach and gut fluid, Caco-2 gut cell model, human liver fractions Diosgenin and dioscin (compounds from Dioscorea villosa)
isolated compounds Lab concentrations Lab
Dioscin partly turned into diosgenin in simulated stomach fluid (24.2%) and gut fluid (2.4%). Diosgenin was stable in liver microsomes but disappeared in the S9 fraction (half-life 11.3 minutes), pointing to phase II metabolism. Diosgenin was pushed back out of cells by P-glycoprotein. Diosgenin and dioscin inhibited CYP3A4 (IC50 17 and 33 micromolar); the other enzymes were not affected.
CYP3A4 IC50 17 micromolar (diosgenin), 33 micromolar (dioscin).
Methods, limits and funding

Outcomes: Stability, gut-cell transport, liver metabolism, effects on drug-metabolising enzymes (CYP3A4, 2D6, 2C9, 1A2)

Limitations: Test-tube study. Lab levels are not the same as levels in blood after a supplement.

Funding and conflicts: No conflict declared

Read: abstract

Mazzio 2021
Effects of Wild Yam Root (Dioscorea villosa) Extract on the Gene Expression Profile of Triple-negative Breast Cancer Cells.
Cancer Genomics Proteomics · PMID 34697066 · DOI
Laboratory research
in-vitro
MDA-MB-231 triple-negative breast cancer cells Wild yam root (Dioscorea villosa) extract
root Sub-lethal concentrations (not stated in the abstract) Cell culture · vs Untreated cells
The authors note the extract contains detergent-like saponins that can break up cell membranes and kill cells, which confuses cancer-cell tests. At doses below killing, 346 genes changed: signals for inflammation, TNF and COX2 went up, as did cholesterol and steroid-making genes, while cell division genes went down.
346 of 48,226 transcripts changed.
Methods, limits and funding

Outcomes: Gene expression changes

Limitations: Cell-line study. Detergent-like cell damage is a key limit on reading these results as anti-cancer.

Funding and conflicts: No conflict declared

Read: abstract

Medigovic 2014
Diosgenin does not express estrogenic activity: a uterotrophic assay.
Can J Physiol Pharmacol · PMID 24708211 · DOI
Animal research
animal
Immature female rats Diosgenin (purified), oral
isolated compound 20, 100 or 200 mg/kg a day 3 days · vs Ethinylestradiol (positive control) and vehicle
Diosgenin did not change uterine weight, womb lining or vaginal tissue, or the receptor staining. The estrogen control did.
No estrogen-like effect at 20 to 200 mg/kg in this rat test.
Methods, limits and funding

Outcomes: Uterine weight and tissue changes; ER-alpha, progesterone receptor and lactoferrin staining

Limitations: Rats, 3 days, purified diosgenin only.

Funding and conflicts: Not stated in the abstract

Read: abstract

Memorial Sloan Kettering Cancer Center 2026
Wild yam root: patient and clinician summary (Memorial Sloan Kettering Cancer Center, About Herbs)
MSK Integrative Medicine, About Herbs · Source
Authoritative guidance
Clinical summary of the evidence for wild yam Wild yam (Dioscorea villosa, D. alata)
root
Limited, mixed evidence for menopausal symptoms. Diosgenin acts like estrogen and progesterone in animals and can be converted to steroid compounds in the laboratory, but there is no evidence that the human body can convert diosgenin into progesterone. Because wild yam has estrogenic effects, patients with hormone-sensitive cancers should talk to their physicians before use. A topical D. villosa formula was ineffective in one small trial; an oral D. alata formula beat placebo in another. D. villosa caused kidney injury via pro-fibrotic pathways in animal models.
Methods, limits and funding

Outcomes: Evidence for menopause symptoms, mechanism and safety

Limitations: Summary page, not original research. The dosage section is for OneMSK patients only and was not seen. Cites studies listed in this file.

Funding and conflicts: Cancer centre; no product promoted

Read: full-text

NCBI 2026
NCBI Taxonomy: Dioscorea villosa (taxid 330167)
NCBI Taxonomy · Source
Authoritative guidance
Not applicable Dioscorea villosa
unspecified
One matching record, taxid 330167.
Methods, limits and funding

Outcomes: Reference record

Limitations: Search by name only; lineage not read in full.

Read: summary-only

NCCIH 2026
Regulator checks for wild yam: NCCIH page, LiverTox/LactMed Bookshelf search, EMA
Web checks 2026-10-25 · Source
Authoritative guidance
Not applicable Wild yam / Dioscorea
unspecified
https://www.nccih.nih.gov/health/wild-yam returned 404. A PubMed Bookshelf search for wild yam or Dioscorea in LiverTox and LactMed returned no records. The EMA site refused automated access (401), so an EMA/HMPC monograph could not be checked.
Methods, limits and funding

Outcomes: Whether regulators or reference books have a wild yam entry

Limitations: Absence of a hit is not proof there is no entry.

Read: summary-only

Park 2009
Estrogen activities and the cellular effects of natural progesterone from wild yam extract in mcf-7 human breast cancer cells.
Am J Chin Med · PMID 19222119 · DOI
Laboratory research
in-vitro
MCF-7 human breast cancer cells Wild yam extract (species not given in the abstract)
unspecified Cell culture · vs 17beta-estradiol
The extract raised progesterone receptor and pS2 mRNA, less than estradiol; lowered estrogen receptor alpha protein; and slowed MCF-7 proliferation. The authors call it a weak phytoestrogen.
Weaker than estradiol; no numbers in the abstract.
Methods, limits and funding

Outcomes: Progesterone receptor and pS2 gene activity, estrogen receptor alpha protein, cell proliferation

Limitations: Cell-culture only. Does not show any effect in people.

Funding and conflicts: Not stated in the abstract

Read: abstract

PubChem 2026
PubChem: Diosgenin (CID 99474, C27H42O3, MW 414.6)
PubChem PUG REST · Source
Authoritative guidance
Not applicable Diosgenin
isolated compound
CID 99474, formula C27H42O3, molecular weight 414.6.
Methods, limits and funding

Outcomes: Reference record

Limitations: Property lookup only.

Read: summary-only

PubChem 2026
PubChem: Dioscin (CID 119245, C45H72O16, MW 869.0)
PubChem PUG REST · Source
Authoritative guidance
Not applicable Dioscin
isolated compound
CID 119245, formula C45H72O16, molecular weight 869.0.
Methods, limits and funding

Outcomes: Reference record

Limitations: Property lookup only.

Read: summary-only

Raj 2023
Dioscorea Villosa (Wild Yam) Root Extract.
Int J Toxicol · PMID 37751575 · DOI
Systematic review
animal
Review of new data since the 2004 assessment Dioscorea villosa root extract (cosmetic ingredient)
rhizome Cosmetic use
The expert panel reviewed new information and reaffirmed its 2004 conclusion that the extract is safe as used in cosmetics at the concentrations described.
Conclusion reaffirmed.
Methods, limits and funding

Outcomes: Safety as a cosmetic ingredient

Limitations: Short summary only. Covers cosmetic use, not supplements. Sponsored by the Cosmetic Ingredient Review.

Funding and conflicts: Supplement sponsored by the Cosmetic Ingredient Review

Read: abstract

Sato 2024
The effect of Dioscorea esculenta powder on prostaglandin E(2) and cytochrome c oxidase subunit 2 levels, menstrual pain, and premenstrual syndrome in young women: A randomized double-blind controlled trial.
Nutr Health · PMID 36217795 · DOI
Controlled trial
10
Healthy young women in Japan
Dioscorea esculenta powder (a different yam species)
unspecified 300 mg a day 4 weeks, then 4-week washout and switch · vs Placebo
PGE2 and COX-2 were lower after the yam than after placebo (p = 0.038, p = 0.042). VAS pain and DRSP scores were lower (p = 0.046, p = 0.035).
p-values only in the abstract.
Methods, limits and funding

Outcomes: Plasma PGE2 and COX-2; menstrual pain (VAS, McGill); PMS (DRSP)

Limitations: Only 10 women; different species; very small crossover trial.

Funding and conflicts: No conflicts declared

Read: abstract

Semwal 2022
Diosgenin: An Updated Pharmacological Review and Therapeutic Perspectives.
Oxid Med Cell Longev · PMID 35677108 · DOI
Review
Review of lab, animal and clinical studies of diosgenin Diosgenin (purified compound from several plants)
isolated compound
Preclinical studies show promising effects on cancer, brain protection, artery disease, asthma and bone. The authors say clinical studies show diosgenin is non-toxic and has promising effects on cognitive function and menopause, but that better trials are needed.
Narrative review; no pooled numbers.
Methods, limits and funding

Outcomes: Pharmacological effects and safety of diosgenin

Limitations: Narrative review, not a systematic review of trials; includes plants other than wild yam.

Funding and conflicts: No conflict declared

Read: abstract

Tohda 2017
Diosgenin-Rich Yam Extract Enhances Cognitive Function: A Placebo-Controlled, Randomized, Double-Blind, Crossover Study of Healthy Adults.
Nutrients · PMID 29064406 · DOI
Controlled trial
28
Healthy adults in Toyama, Japan, aged 20 to 81
Diosgenin-rich yam (Dioscorea) extract in olive oil soft capsules (species not stated in the abstract)
unspecified Dose not stated in the abstract 12 weeks per period, with a 6-week washout · vs Placebo capsules
Total RBANS score rose significantly with the extract; of 12 subtests, semantic fluency improved significantly. No adverse effects were reported.
Total RBANS score higher with extract; numbers not in the abstract.
Methods, limits and funding

Outcomes: Japanese version of the RBANS cognitive test; adverse effects by blood tests

Limitations: Small; healthy adults, so it says little about memory loss; species and dose not stated in the abstract; authors include a company-affiliated researcher (Resilio) although they declare no conflict.

Funding and conflicts: Authors declare no conflict of interest; one author lists a company affiliation (Resilio Company Limited)

Read: abstract

Wang 2024
The genus Dioscorea L. (Dioscoreaceae), a review of traditional uses, phytochemistry, pharmacology, and toxicity.
J Ethnopharmacol · PMID 38552992 · DOI
Review
Review of about 600 Dioscorea species Genus Dioscorea (many species)
unspecified Literature 1950 to 2022
Over 1,000 compounds have been isolated. Traditional uses are mainly in Asia and Africa; North American traditional use is rarely recorded. Some studies point to possible toxicity at high doses, and the authors call for more work on acute and chronic toxicity.
Narrative review.
Methods, limits and funding

Outcomes: Traditional uses, compounds, pharmacology and toxicity

Limitations: Covers the whole genus, so findings cannot be assumed for D. villosa.

Funding and conflicts: No conflict declared

Read: abstract

Wojcikowski 2008
Dioscorea villosa (wild yam) induces chronic kidney injury via pro-fibrotic pathways.
Food Chem Toxicol · PMID 18662738 · DOI
Animal research
animal
Sprague-Dawley rats, 4 per group per time point Dioscorea villosa rhizome extract in food
rhizome 0.79 g/kg a day 7, 14 and 28 days · vs Untreated rats
By 28 days treated kidneys had more collagen, vimentin, TGF-beta1, NF-kappaB, ED-1, CTGF and alpha-SMA (signs of scarring and inflammation). Liver showed more ED-1 and TGF-beta1 at 28 days. No sudden kidney or liver toxicity. The authors say long-term use may best be avoided, especially with weak kidneys or with drugs that affect the kidneys.
Significant increase in kidney scarring markers at 28 days.
Methods, limits and funding

Outcomes: Kidney and liver tissue: scarring (collagen), inflammation and growth-factor markers

Limitations: Rats; very small groups (4 per group); high dose; 28 days. Human relevance unknown.

Funding and conflicts: Not stated in the abstract

Read: abstract

Wu 2005
Estrogenic effect of yam ingestion in healthy postmenopausal women.
J Am Coll Nutr · PMID 16093400 · DOI
Non randomized trial
22
Healthy postmenopausal women in Taiwan (24 enrolled, 22 finished)
Whole food yam (Dioscorea alata, a different species), eaten in place of rice
tuber (food) 390 g of yam in 2 of 3 daily meals, replacing staple food 30 days
Serum estrone rose 26% and sex hormone binding globulin (SHBG) rose 9.5%; estradiol rose 27% (near significant). DHEA-S, androstenedione, testosterone, FSH and LH did not change. Urinary 16alpha-hydroxyestrone fell 37%. Plasma cholesterol fell 5.9%. LDL oxidation lag time lengthened 5.8% and urinary isoprostanes fell 42%. Sweet potato control: no change in estrone, estradiol, SHBG.
Estrone +26%, SHBG +9.5%, cholesterol -5.9%, isoprostanes -42%.
Methods, limits and funding

Outcomes: Blood lipids, sex hormones, urinary estrogen metabolites, oxidant stress

Limitations: One-arm study with no placebo group; a historical sweet potato study as the control; very large daily food amount; D. alata food yam, not wild yam.

Funding and conflicts: Not stated in the abstract

Read: abstract

Yen 2005
Diosgenin induces hypoxia-inducible factor-1 activation and angiogenesis through estrogen receptor-related phosphatidylinositol 3-kinase/Akt and p38 mitogen-activated protein kinase pathways in osteoblasts.
Mol Pharmacol · PMID 15998873 · DOI
Laboratory research
in-vitro
Mouse bone-forming cells (MC3T3-E1) Diosgenin from wild yam root (D. villosa)
root Cell concentrations (not stated in the abstract) Cell culture · vs Estrogen receptor blockers (ICI 182,780, tamoxifen)
Diosgenin displaced radio-labelled estradiol from the estrogen receptor (IC50 10 nM) and raised VEGF-A in the cells through estrogen-receptor-related signals that tamoxifen and ICI 182,780 blocked.
IC50 10 nM for estrogen receptor binding in the assay.
Methods, limits and funding

Outcomes: VEGF-A, HIF-1alpha, estrogen receptor binding

Limitations: Mouse cells in a dish. Purified diosgenin, not the whole root.

Funding and conflicts: Not stated in the abstract

Read: abstract

Zava 1998
Estrogen and progestin bioactivity of foods, herbs, and spices.
Proc Soc Exp Biol Med · PMID 9492350 · DOI
Laboratory research
in-vitro
Over 150 herb extracts tested on human breast cancer cells, plus saliva tests after eating some foods and products Plant extracts including (in saliva tests) wild Mexican yam products containing diosgenin
unspecified · vs Soy milk, progesterone, medroxyprogesterone
Many herbs bound the estrogen receptor (agonists) or progesterone receptor (neutral or antagonists). Saliva tests were done after soy milk, progesterone, medroxyprogesterone acetate or wild Mexican yam products containing diosgenin. The abstract does not report what the yam products did. Wild yam is not named among the top receptor-binding herbs in the abstract.
No yam-specific numbers in the abstract.
Methods, limits and funding

Outcomes: Binding to estrogen and progesterone receptors in cells; saliva receptor-binding after consumption

Limitations: Abstract does not give the yam result. Saliva receptor binding is not the same as hormone levels in blood. Company-based authors (Aeron Biotechnology).

Funding and conflicts: Authors from Aeron Biotechnology (a hormone-testing laboratory)

Read: abstract

What we do not know yet

  • What the evidence supports: nothing about wild yam is above low certainty. Menopause symptoms with a cream and with other yam species, and thinking skills, are low; cholesterol is mixed; period pain is very low; blood sugar, joints, bone and cancer cells are lab or animal only; the progesterone-conversion claim is not supported.
  • What is uncertain: the cream trial was small and null, the better oral results came from Dioscorea alata, and the yam species and dose in the cognition trial are unknown.
  • What is not known: oral wild yam root has no menopause trial, there are no pregnancy, breastfeeding, child or drug-interaction studies, long-term safety is unstudied, and EMA, Commission E and WHO status could not be confirmed.

How new research is added

New studies are found by a saved PubMed search and are placed in a review queue. A person reads each one before it changes any evidence rating or safety wording. New publications never change ratings automatically.

Lab markers

What changed in blood or saliva tests during trials. A changed number is not the same as feeling or being healthier, and we give no "normal ranges".

Hormonal 2

●

Estradiol and FSH (menopause hormone markers)

No clear change in trials

Estradiol is the main estrogen. FSH is a pituitary hormone that rises after menopause. In the cream trial estradiol was undetectable in most women and FSH was high, as expected after menopause.

Low certainty
Results and what it means

Why it was measured

To see whether a wild yam product acts like a hormone treatment.

Statistical vs. clinical meaning

The cream did not shift these markers. The food-yam study did, but it had no placebo group and used another species. A shift in a lab marker is not the same as relief of symptoms.

Safety implication

Any real change in estrogen markers is a reason for caution in people with hormone-sensitive cancer or conditions.

StudyResultPeopleProduct
11No change in estradiol or FSH after 3 months of wild yam cream compared with placebo.23 menopausal womenTopical D. villosa cream, 3 months
28Estrone rose 26%, estradiol rose 27% (near significant), SHBG rose 9.5%; FSH and LH did not change.22 postmenopausal women, one-arm study390 g a day of D. alata food yam, 30 days

11 28

●

Progesterone (blood and saliva)

No clear change in trials

The hormone the claim says wild yam turns into. It was measured in blood and saliva in the cream trial.

Low certainty
Results and what it means

Why it was measured

To test directly whether a wild yam cream raises progesterone.

Statistical vs. clinical meaning

One small trial; consistent with the authoritative statement that there is no evidence of conversion in the body.

Safety implication

Do not use a wild yam product as a progesterone replacement.

StudyResultPeopleProduct
11No change in serum or salivary progesterone after 3 months of wild yam cream.23 menopausal womenTopical D. villosa cream, 3 months

11 16

Metabolic 1

↕

Total cholesterol

Mixed results in trials

Total cholesterol in blood plasma or serum.

Mixed findings
Results and what it means

Why it was measured

A common marker of heart risk.

Statistical vs. clinical meaning

A small change in a marker is not the same as fewer heart problems.

Safety implication

None.

StudyResultPeopleProduct
28Fell 5.9% after 30 days of heavy D. alata food intake (one-arm study).22 postmenopausal women390 g a day of yam
11No change in total cholesterol, triglycerides or HDL after 3 months.23 menopausal womenTopical wild yam cream

28 11

Other 4

▼

Greene Climacteric Scale (menopause symptom score)

Lowered in trials

A questionnaire where women score menopause symptoms such as anxiety, sleep and aches. A lower score means fewer symptoms.

Low certainty
Results and what it means

Why it was measured

The usual way to measure overall menopause symptoms in trials.

Statistical vs. clinical meaning

Statistically significant; the abstract gives no size of change, so clinical importance is unknown. Different yam species.

Safety implication

None reported.

StudyResultPeopleProduct
9Total score lower than placebo at 12 months (p < 0.01); anxiety and tension items improved most.50 menopausal womenOral D. alata extract, 12 months

9

▲

RBANS total score (thinking test)

Raised in trials

A test battery that scores memory, attention, language and visual skills. A higher total means better scores.

Low certainty
Results and what it means

Why it was measured

To test whether a diosgenin-rich yam extract improves thinking.

Statistical vs. clinical meaning

Statistically significant in a small trial; practical importance unknown.

Safety implication

No adverse effects reported.

StudyResultPeopleProduct
25Total RBANS score rose after 12 weeks; semantic fluency was the one subtest with a significant gain.28 healthy adultsDiosgenin-rich yam extract in olive oil, 12 weeks, crossover

25

▼

Prostaglandin E2 and COX-2 (inflammation chemicals)

Lowered in trials

Chemicals involved in pain and inflammation, including period pain.

Very low certainty
Results and what it means

Why it was measured

To test whether a yam powder acts on the pathway of period pain.

Statistical vs. clinical meaning

Tiny trial, different species.

Safety implication

None reported.

StudyResultPeopleProduct
23Lower PGE2 (p = 0.038) and COX-2 (p = 0.042) than placebo after 4 weeks.10 young womenD. esculenta powder 300 mg a day

23

▼

Urinary isoprostanes (oxidative stress marker)

Lowered in trials

A lab marker of oxidative damage; lower means less measured damage.

Very low certainty
Results and what it means

Why it was measured

Used as a general marker of oxidant stress.

Statistical vs. clinical meaning

One-arm study without a placebo group, a different species and a very large food amount.

Safety implication

None.

StudyResultPeopleProduct
28Fell 42% and LDL oxidation lag time lengthened 5.8% after 30 days of D. alata food yam.22 postmenopausal women390 g a day of food yam

28

Safety

What studies and official sources say about side effects, medicines and who should check first. Each point shows what kind of evidence it comes from.

Main points to know 6
  • Hormone-sensitive conditions: talk to a doctor first. Lab studies show wild yam extract and diosgenin have weak estrogen-like activity in cells: the extract switched on estrogen-responsive genes in breast cancer cells (Park 2009), and diosgenin displaced estradiol from the estrogen receptor in a binding test (Yen 2005). Rat tests were reassuring: purified diosgenin did not stimulate the womb in a standard rat test (Medigovic 2014) and a specified cosmetic extract showed no estrogen-like effect in a juvenile rat test (CIR 2004). MSK advises people with hormone-sensitive cancers to talk to their doctors before use. This covers breast, womb and ovarian cancer; the same precaution is reasonable for other estrogen-sensitive conditions, but that wider list is the compiler's inference, not a finding. Laboratory research 19 29 15 6 16
  • Not a replacement for progesterone. The idea that the body turns wild yam into progesterone is not supported (see the benefits tab). A wild yam cream does not protect the womb lining the way prescribed progesterone does during estrogen therapy. Never swap a prescribed hormone for a wild yam product. Authoritative guidance 16 11
  • Kidney scarring signals in rats. Rats fed a Dioscorea villosa rhizome extract for 28 days showed more scarring and inflammation markers in the kidney and more inflammation markers in the liver, with no sudden toxicity. The authors suggest long-term use may best be avoided, especially with weak kidneys or with drugs that affect the kidneys. Human relevance is unknown. Animal research 27 16
  • Short-term cream use: no side effects in the one trial. Women using a wild yam cream for 3 months reported no significant side effects compared with placebo (23 women). The cosmetic safety panel judged one specified wild yam root extract safe for cosmetic use at the concentrations described. Undiluted extract irritated rabbit skin; a 10% dilution did not. Controlled trial 11 6 22
  • Pregnancy and breastfeeding: no safety data. No pregnancy or breastfeeding study of wild yam was found. Because of its possible hormone-like effects, avoiding it unless a doctor agrees is the careful choice. This is a precaution, not a proven harm. Pharmacological theory 19
  • Products vary and may be mislabelled. Total steroid-like compounds in commercial Dioscorea products ranged from 0.9 to 28.6 mg per daily intake in one lab survey. Another lab study shows that wild yam can be confused with a related species, Dioscorea cayenensis, and gives markers to tell them apart. Authoritative guidance 3 4
Side effects 4
EffectHow oftenSeverity and recoveryEvidence
Skin irritation (undiluted extract); no side effects at normal cream use in one trial
Undiluted extract was irritating to rabbit skin and mildly to eyes; 10% was not irritating; no sensitization in guinea pigs. The 3-month cream trial found no significant side effects.
Not establishedMild
Expected to settle when stopped (not studied)
Animal research 6 11
Kidney scarring and inflammation markers (rats, 28 days)
Dose was 0.79 g/kg a day in food. No sudden kidney or liver toxicity.
Not establishedNot known in people
Not studied
Animal research 27
Possible hormone-like effects (estrogen-like in cells; smaller adrenal glands in rats given implanted diosgenin)
The adrenal finding used a slow-release diosgenin implant, not oral wild yam; the authors flagged possible endocrine complications.
Not establishedUnknown
Unknown
Laboratory research 19 5
Stomach and gut upset (nausea, loose stools) at higher oral amounts
NOT verified. This effect is often listed on consumer sites for wild yam, but none of the trials read reported it, and no source read gives a frequency. A genus review only says high doses of some Dioscorea species may be toxic. The saponins are detergent-like (Mazzio 2021), so irritation of the gut lining is plausible but untested.
Not establishedNot known
Not known
Traditional use 26
Liver

No LiverTox chapter for wild yam was found (a Bookshelf search returned no record), and no human case of liver injury from Dioscorea villosa was found in the sources read. In rats fed the extract for 28 days there was more liver inflammation marker (ED-1, TGF-beta1) around the central veins without sudden toxicity, while a separate 30-day rodent study at 1 g/kg a day found only unremarkable blood chemistry and tissue changes. 27 12 18

How often. No frequency can be given: no human liver reports were found.

Monitoring. No monitoring protocol exists. Anyone with liver disease should ask a doctor or pharmacist before using it.

This is a safety connection. It is not evidence that Wild yam supports liver health.

Medicines and supplements 5
WithWhy it mattersImportanceEvidenceWhat to do
Estrogen, progesterone, hormone therapy, birth control pills, tamoxifen and aromatase inhibitors
drug
Wild yam compounds bind or act weakly at estrogen receptors in the lab, so they could in theory add to or block the effect of hormone-active medicines.Unknown. No human interaction study was found.Pharmacological theory Not enough evidence 19 29If you take any hormone-related medicine, check with your doctor or pharmacist before using wild yam.
Medicines broken down by the liver enzyme CYP3A4 (many common drugs)
drug
Diosgenin and dioscin inhibited CYP3A4 in human liver test-tube assays (IC50 17 and 33 micromolar). Other enzymes tested (CYP2D6, 2C9, 1A2) were not affected. Diosgenin is also moved out of gut cells by P-glycoprotein.Unknown. Test-tube levels may not be reached in the body.Laboratory research Very low certainty 13Ask a pharmacist if you take medicines with a narrow safety margin.
Medicines that affect the kidneys
drug
The rat study suggests wild yam extract can increase kidney scarring markers; the authors advise avoiding long-term use with drugs that alter kidney function.Unknown in people.Animal research Very low certainty 27Ask your doctor, especially if you have kidney disease.
Diabetes medicines
drug
Rodent studies of yam extracts show lower blood sugar. No human data for wild yam.Theoretical add-on effect.Animal research Not enough evidence 1If you take diabetes medicines, ask a doctor before using a yam extract.
Other herbs with estrogen-like activity (for example soy, red clover)
herb
Additive hormone-like activity is possible in theory.Unknown; not studied.Pharmacological theory Not enough evidence 30 19Tell your clinician about every supplement you take.
Who should check first 6
SituationAdviceEvidence
Breast, womb or ovarian cancer, or a past hormone-sensitive cancerTalk to your cancer team before using. MSK specifically advises this for hormone-sensitive cancers.Authoritative guidance 16 19
Other estrogen-sensitive conditions (endometriosis, fibroids, estrogen-driven bleeding)Precaution only: this is inferred from lab estrogen-like activity, not a documented harm. Ask your doctor.Pharmacological theory 19 29
Kidney diseaseAvoid long-term use unless your doctor agrees. Based on a rat study.Animal research 27
Pregnancy and breastfeedingNo safety data. Avoid unless a doctor agrees.Pharmacological theory 19
ChildrenNo studies found. Do not give wild yam supplements to children.Pharmacological theory 18
Replacing prescribed progesterone or estrogenDo not stop or replace a prescribed hormone with wild yam without your doctor.Authoritative guidance 16
Overdose, product quality and regulators

Summary. Wild yam appears to have low acute toxicity in animals, but the evidence in people is thin and long-term use has not been studied. Do not confuse it with the dangerous steroid drugs made from diosgenin, or with wild-harvested yams of other species.

Animal. CIR extract: one of ten rats died at 2 g/kg by mouth; no toxicity at 0.5 g/kg. A separate dry extract at 5 g/kg once and 1 g/kg a day for 30 days showed only unremarkable changes in rodents. 28 days of 0.79 g/kg a day in rats raised kidney scarring markers.

Human doses studied. A cream for 3 months (23 women). An oral diosgenin-rich yam extract for 12 weeks (28 adults). No trial of oral wild yam root for menopause was found.

High dose or long term signals. Kidney scarring markers in rats at 28 days; smaller adrenal glands in rats with implanted diosgenin; a genus review notes possible toxicity at high doses of some Dioscorea.

Overdose response. No human overdose reports found.

Genotoxicity. CIR: gene-damage tests were negative except one Ames strain at one dose by one method, for a specified extract.

Toxic plant parts. Rhizome (root) is the medicinal part. Other parts were not assessed.

Supplements are not standard: one lab survey found steroid-like compounds ranging from 0.9 to 28.6 mg per daily intake, and lab methods can show whether D. villosa is really present. The cosmetic panel urged a limit on pesticide residues.

Strength varies widely. 0.9 to 28.6 mg total steroid compounds per daily intake across commercial solid products. 3

Species mix-ups. D. villosa and D. cayenensis can be told apart by their saponins, which helps find mislabelled or spiked products. 4

Pesticide residues. The cosmetic safety panel urged manufacturers to keep pesticide residues to no more than 40 ppm (10 ppm for any single residue). 6

Creams that claim to contain progesterone. Not checked: whether any wild yam cream on the market has natural or synthetic progesterone added was not looked into. This is a gap, not a finding.

BodyActionDate
NCCIH (US National Center for Complementary and Integrative Health) (US)No wild yam page: https://www.nccih.nih.gov/health/wild-yam returned 404. Not found. source2026-10-25
Cosmetic Ingredient Review Expert Panel (US)Concluded wild yam root extract is safe as used in cosmetics (2004) and reaffirmed it in 2023, for extracts with a similar chemical profile (diosgenin up to 3.5%). Industry-supported body. source2026-10-25
When to get medical help
  • Hives, swelling of the face or lips, or trouble breathing after using a wild yam product: stop and seek emergency care.
  • Much less urine than usual, new swelling of the legs, or blood in the urine while using a yam supplement: stop and see a doctor (kidney concern from rat data).
  • Unexpected vaginal bleeding, a new breast lump, or breast pain while using a product with possible hormone-like effects: stop and see a doctor.
  • Severe or lasting vomiting, diarrhea or stomach pain after taking a yam supplement: stop and see a doctor.

Stop the supplement and contact a clinician or emergency service. In the US, Poison Control is 1-800-222-1222.

General information only, not medical advice. Ask a clinician or pharmacist before use, especially with medicines, in pregnancy or with a health condition. See the Natural Remedy Safety guide.

Frequently asked questions

Does wild yam turn into progesterone in the body?

No evidence supports this. Memorial Sloan Kettering says there is no evidence the body can convert diosgenin into progesterone. Drug makers do it in the lab. In the one wild yam cream trial, progesterone in blood and saliva did not change.

16 11

Does wild yam cream help menopause symptoms?

In the only controlled trial of a wild yam cream (23 women, 3 months), it did no better than a placebo cream. Both brought a small improvement in flushing. Reviews of herbs for hot flashes did not find consistent evidence for wild yam.

11 10 7

Is wild yam the same as the yam I eat or as other Dioscorea products?

No. Wild yam is Dioscorea villosa. Trials with better results used other species such as Dioscorea alata and Dioscorea esculenta, so they cannot be taken as proof for wild yam.

9 28 23 4

Is wild yam safe for people with hormone-sensitive cancer?

Not known. Lab studies show weak estrogen-like activity, and Memorial Sloan Kettering advises people with hormone-sensitive cancers to talk to their doctors before use. Ask your cancer team.

16 19 29

Does wild yam have estrogen-like effects?

Weak ones in cells. Diosgenin bound the estrogen receptor in a lab test and the extract acted as a weak phytoestrogen in breast cancer cells. Purified diosgenin did not stimulate the womb in rats, and the cream trial found no change in estradiol or FSH. The effect in people is unproven.

19 29 15 11

Is wild yam safe in pregnancy or when breastfeeding?

No safety data were found, so avoid it unless a doctor agrees, given its possible hormone-like effects.

19 18

Does wild yam harm the kidneys or liver?

In rats fed the extract for 28 days there were more kidney scarring markers and some liver inflammation markers, without sudden toxicity. A separate 30-day rodent study found unremarkable results. No human cases were found, and no LiverTox entry exists.

27 12 18

Does wild yam interact with medicines?

No human interaction study exists. In test tubes diosgenin and dioscin slowed CYP3A4, a liver enzyme that breaks down many medicines. Because of possible hormone-like effects, tell your doctor if you take hormones, birth control, tamoxifen, diabetes medicines or kidney-affecting drugs.

13 19 27

Does wild yam cause stomach upset?

It is often listed as a side effect, but none of the trials read reported it and no frequency is known. This is not verified.

11 25 26

Is wild yam approved by regulators?

No wild yam monograph from the European Medicines Agency and no NCCIH, LiverTox or LactMed entry was found; the EMA site could not be checked directly. A cosmetic safety panel judged a specified wild yam root extract safe for cosmetics. In the US it is sold as a supplement or cream.

18 6 22 16

Do supplements all contain the same amount?

No. One lab survey found total steroid-like compounds ranging from 0.9 to 28.6 mg per daily intake across products, and lab methods can tell wild yam from a related species. Look for products that name Dioscorea villosa and the plant part.

3 4

Can wild yam improve memory?

One small trial of 28 healthy adults found a better score on a thinking test with a diosgenin-rich yam extract after 12 weeks. The species was not stated and it has not been repeated.

25 24

Explore by health goal

Menopause SupportWomens WellnessHormone BalanceInflammation BalanceAnxiety SupportBetter SleepMemory SupportCognitive PerformanceBrain HealthCholesterol BalanceHeart HealthBlood Sugar BalanceMetabolic HealthJoint SupportHealthy Aging

Editorial transparency
Written by
AlternativeMed editorial team. Research compiled with AI assistance, then checked against PubMed records.
Medical review
None. This page has not been reviewed by a physician or pharmacist.
First published
2026-10-25
Last substantive update
2026-10-25
How we research
We searched PubMed, read the Memorial Sloan Kettering wild yam page, and checked the plant name in GBIF and NCBI Taxonomy and compounds in PubChem. Only abstracts were read for nearly all studies. Some sources were not verified: no EMA herbal monograph was found and the EMA site could not be checked; the NCCIH wild yam page returned 404; no LiverTox or LactMed entry was found; Commission E, WHO and FDA were not checked directly. Certainty ratings are the compiler's own reading, not formal grades. No study is cited that we could not verify.
How we rate evidence
See "How we rate evidence" in the Evidence tab.
Independence
No product is promoted on this page. No affiliate links are shown. If one is added later it will be labelled and kept apart from the evidence.
Sources 30

Each source was opened and checked. Where we read only the abstract, it says so. The small numbers in the text point here.

  1. Alharazi WZ, McGowen A, Rose P, et al.. Could consumption of yam (Dioscorea) or its extract be beneficial in controlling glycaemia: a systematic review.. Br J Nutr. 2022. PMID 34521490. DOI 10.1017/S0007114521003706. (abstract)
  2. Aumsuwan P, Khan SI, Khan IA, et al.. Evaluation of wild yam (Dioscorea villosa) root extract as a potential epigenetic agent in breast cancer cells.. In Vitro Cell Dev Biol Anim. 2015. PMID 25148825. DOI 10.1007/s11626-014-9807-5. (abstract)
  3. Avula B, Wang YH, Ali Z, et al.. Chemical fingerprint analysis and quantitative determination of steroidal compounds from Dioscorea villosa, Dioscorea species and dietary supplements using UHPLC-ELSD.. Biomed Chromatogr. 2014. PMID 24019066. DOI 10.1002/bmc.3019. (abstract)
  4. Avula B, Wang YH, Wang M, et al.. Characterization of steroidal saponins from Dioscorea villosa and D. cayenensis using ultrahigh performance liquid chromatography/electrospray ionization quadrupole time-of-flight mass spectrometry.. Planta Med. 2014. PMID 24510365. DOI 10.1055/s-0033-1360330. (abstract)
  5. Benghuzzi H, Tucci M, Eckie R, Hughes J. The effects of sustained delivery of diosgenin on the adrenal gland of female rats.. Biomed Sci Instrum. 2003. PMID 12724916. (abstract)
  6. Cosmetic Ingredient Review Expert Panel (no authors listed). Final report of the amended safety assessment of Dioscorea Villosa (Wild Yam) root extract.. Int J Toxicol. 2004. PMID 15513824. DOI 10.1080/10915810490499055. (abstract)
  7. Depypere HT, Comhaire FH. Herbal preparations for the menopause: beyond isoflavones and black cohosh.. Maturitas. 2014. PMID 24314619. DOI 10.1016/j.maturitas.2013.11.001. (abstract)
  8. GBIF. GBIF backbone match: Dioscorea villosa L. (ACCEPTED, key 2754553). GBIF API. 2026. (summary-only)
  9. Hsu CC, Kuo HC, Chang SY, et al.. The assessment of efficacy of Diascorea alata for menopausal symptom treatment in Taiwanese women.. Climacteric. 2011. PMID 20653397. DOI 10.3109/13697137.2010.498594. (abstract)
  10. Kelley KW, Carroll DG. Evaluating the evidence for over-the-counter alternatives for relief of hot flashes in menopausal women.. J Am Pharm Assoc. 2010. PMID 20833608. DOI 10.1331/JAPhA.2010.09243. (abstract)
  11. Komesaroff PA, Black CV, Cable V, et al.. Effects of wild yam extract on menopausal symptoms, lipids and sex hormones in healthy menopausal women.. Climacteric. 2001. PMID 11428178. (abstract)
  12. Lima CM, Lima AK, Melo MG, et al.. Bioassay-guided evaluation of Dioscorea villosa - an acute and subchronic toxicity, antinociceptive and anti-inflammatory approach.. BMC Complement Altern Med. 2013. PMID 23889998. DOI 10.1186/1472-6882-13-195. (abstract)
  13. Manda VK, Avula B, Ali Z, et al.. Characterization of in vitro ADME properties of diosgenin and dioscin from Dioscorea villosa.. Planta Med. 2013. PMID 23970424. DOI 10.1055/s-0033-1350699. (abstract)
  14. Mazzio E, Almalki A, Darling-Reed SF, et al.. Effects of Wild Yam Root (Dioscorea villosa) Extract on the Gene Expression Profile of Triple-negative Breast Cancer Cells.. Cancer Genomics Proteomics. 2021. PMID 34697066. DOI 10.21873/cgp.20294. (abstract)
  15. Medigovic I, Ristic N, Zivanovic J, et al.. Diosgenin does not express estrogenic activity: a uterotrophic assay.. Can J Physiol Pharmacol. 2014. PMID 24708211. DOI 10.1139/cjpp-2013-0419. (abstract)
  16. Memorial Sloan Kettering Cancer Center. Wild yam root: patient and clinician summary (Memorial Sloan Kettering Cancer Center, About Herbs). MSK Integrative Medicine, About Herbs. 2026. (full-text)
  17. NCBI. NCBI Taxonomy: Dioscorea villosa (taxid 330167). NCBI Taxonomy. 2026. (summary-only)
  18. NCCIH, NCBI Bookshelf, EMA. Regulator checks for wild yam: NCCIH page, LiverTox/LactMed Bookshelf search, EMA. Web checks 2026-10-25. 2026. (summary-only)
  19. Park MK, Kwon HY, Ahn WS, et al.. Estrogen activities and the cellular effects of natural progesterone from wild yam extract in mcf-7 human breast cancer cells.. Am J Chin Med. 2009. PMID 19222119. DOI 10.1142/S0192415X09006746. (abstract)
  20. PubChem. PubChem: Diosgenin (CID 99474, C27H42O3, MW 414.6). PubChem PUG REST. 2026. (summary-only)
  21. PubChem. PubChem: Dioscin (CID 119245, C45H72O16, MW 869.0). PubChem PUG REST. 2026. (summary-only)
  22. Raj PS, Bergfeld WF, Belsito DV, et al.. Dioscorea Villosa (Wild Yam) Root Extract.. Int J Toxicol. 2023. PMID 37751575. DOI 10.1177/10915818231204230. (abstract)
  23. Sato K, Seto K. The effect of Dioscorea esculenta powder on prostaglandin E(2) and cytochrome c oxidase subunit 2 levels, menstrual pain, and premenstrual syndrome in young women: A randomized double-blind controlled trial.. Nutr Health. 2024. PMID 36217795. DOI 10.1177/02601060221130889. (abstract)
  24. Semwal P, Painuli S, Abu-Izneid T, et al.. Diosgenin: An Updated Pharmacological Review and Therapeutic Perspectives.. Oxid Med Cell Longev. 2022. PMID 35677108. DOI 10.1155/2022/1035441. (abstract)
  25. Tohda C, Yang X, Matsui M, et al.. Diosgenin-Rich Yam Extract Enhances Cognitive Function: A Placebo-Controlled, Randomized, Double-Blind, Crossover Study of Healthy Adults.. Nutrients. 2017. PMID 29064406. DOI 10.3390/nu9101160. (abstract)
  26. Wang Y, Yu D, Zhu S, et al.. The genus Dioscorea L. (Dioscoreaceae), a review of traditional uses, phytochemistry, pharmacology, and toxicity.. J Ethnopharmacol. 2024. PMID 38552992. DOI 10.1016/j.jep.2024.118069. (abstract)
  27. Wojcikowski K, Wohlmuth H, Johnson DW, Gobe G. Dioscorea villosa (wild yam) induces chronic kidney injury via pro-fibrotic pathways.. Food Chem Toxicol. 2008. PMID 18662738. DOI 10.1016/j.fct.2008.06.090. (abstract)
  28. Wu WH, Liu LY, Chung CJ, et al.. Estrogenic effect of yam ingestion in healthy postmenopausal women.. J Am Coll Nutr. 2005. PMID 16093400. DOI 10.1080/07315724.2005.10719470. (abstract)
  29. Yen ML, Su JL, Chien CL, et al.. Diosgenin induces hypoxia-inducible factor-1 activation and angiogenesis through estrogen receptor-related phosphatidylinositol 3-kinase/Akt and p38 mitogen-activated protein kinase pathways in osteoblasts.. Mol Pharmacol. 2005. PMID 15998873. DOI 10.1124/mol.104.010082. (abstract)
  30. Zava DT, Dollbaum CM, Blen M. Estrogen and progestin bioactivity of foods, herbs, and spices.. Proc Soc Exp Biol Med. 1998. PMID 9492350. DOI 10.3181/00379727-217-44247. (abstract)

Where to buy

Check the label first. Whatever you buy, look for these:

  • The plant part and the extract type or ratio on the label
  • A standardized amount of the active compounds, where relevant
  • A third-party testing mark (USP, NSF or ConsumerLab)
  • Interactions: ask a pharmacist if you take medicines, are pregnant or have a medical condition

Talk to a pharmacist or doctor before you start any supplement, especially if you take medicines. See the Safety tab for interactions.

Browse Wild yam on Amazon
Amazon · Several brands to compare
Shop Wild yam on Amazon

Support our free guides: as an Amazon Associate we earn from qualifying purchases. Full disclosure.

Education, not medical advice. This page is for general information. It does not diagnose or treat any condition and is not a substitute for care from a qualified health professional. Natural does not automatically mean safe. Ask a clinician or pharmacist before changing your care, especially if you take medication, are pregnant or breastfeeding, or have a health condition.